Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

16 mai 2024 06h00 HE | Source: South Rampart Pharma

South Rampart Pharma Publishes SRP-001's Unique Pain Relief Mechanism and Phase 1 Trial Results in Scientific Reports

SRP-001 is a novel, non-opioid new chemical entity without abuse, liver, and kidney toxicities present in current pain medications Publication introduces SRP-001 as a safer alternative to existing...
29 sept. 2020 08h00 HE | Source: South Rampart Pharma

South Rampart Pharma Receives $1.9 Million NIH Fast-Track STTR Commercialization Grant to Advance its New Class of Non-Opioid Pain Medicines

NEW ORLEANS, Sept. 29, 2020 (GLOBE NEWSWIRE) -- South Rampart Pharma, a company committed to improving the lives of people suffering from pain by developing a new class of non-opioid pain medicines,...
14 juil. 2020 08h00 HE | Source: South Rampart Pharma

South Rampart Pharma Identifies New Class of Non-Opioid Pain Medicines in European Journal of Medicinal Chemistry Publication

NEW ORLEANS, July 14, 2020 (GLOBE NEWSWIRE) -- South Rampart Pharma, LLC ("South Rampart" or "the Company"), a company committed to improving the lives of people suffering from pain by developing a...